- Home
- JZ vs PASG Comparison
JZ vs PASG Comparison
Compare JZ & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- PASG
- Stock Information
- Founded
- JZ 2011
- PASG 2017
- Country
- JZ China
- PASG United States
- Employees
- JZ N/A
- PASG N/A
- Industry
- JZ Other Consumer Services
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- PASG Health Care
- Exchange
- JZ Nasdaq
- PASG Nasdaq
- Market Cap
- JZ 26.7M
- PASG 31.1M
- IPO Year
- JZ 2022
- PASG 2020
- Fundamental
- Price
- JZ $0.39
- PASG $0.27
- Analyst Decision
- JZ
- PASG Strong Buy
- Analyst Count
- JZ 0
- PASG 3
- Target Price
- JZ N/A
- PASG $7.67
- AVG Volume (30 Days)
- JZ 2.6M
- PASG 240.1K
- Earning Date
- JZ 01-01-0001
- PASG 05-13-2025
- Dividend Yield
- JZ N/A
- PASG N/A
- EPS Growth
- JZ N/A
- PASG N/A
- EPS
- JZ N/A
- PASG N/A
- Revenue
- JZ $34,090,704.00
- PASG N/A
- Revenue This Year
- JZ N/A
- PASG N/A
- Revenue Next Year
- JZ N/A
- PASG N/A
- P/E Ratio
- JZ N/A
- PASG N/A
- Revenue Growth
- JZ N/A
- PASG N/A
- 52 Week Low
- JZ $0.51
- PASG $0.30
- 52 Week High
- JZ $2.34
- PASG $1.64
- Technical
- Relative Strength Index (RSI)
- JZ 27.37
- PASG 34.53
- Support Level
- JZ $0.51
- PASG $0.33
- Resistance Level
- JZ $0.70
- PASG $0.42
- Average True Range (ATR)
- JZ 0.13
- PASG 0.05
- MACD
- JZ -0.04
- PASG -0.00
- Stochastic Oscillator
- JZ 0.18
- PASG 5.82
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.